Johnson & Johnson (JNJ)
NYSE: JNJ
· Real-Time Price · USD
176.30
-0.34 (-0.19%)
At close: Aug 18, 2025, 3:59 PM
176.01
-0.16%
After-hours: Aug 18, 2025, 07:54 PM EDT
Johnson & Johnson Revenue Breakdown
| Period Ending | Dec 29, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 28, 2019 | Dec 29, 2018 | Dec 30, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|
| Innovative Medicine Revenue | 56.96B | 54.76B | 52.56B | 42.2B | 40.73B | 36.26B | 33.46B |
| Innovative Medicine Revenue Growth | +4.03% | +4.18% | +24.56% | +3.59% | +12.35% | +8.34% | n/a |
| MedTech Revenue | 31.86B | 30.4B | 27.43B | 25.96B | 26.99B | 26.59B | 25.12B |
| MedTech Revenue Growth | +4.79% | +10.84% | +5.64% | -3.82% | +1.51% | +5.86% | n/a |
Revenue by Geography
| Period Ending | Dec 29, 2024 | Dec 31, 2023 | Dec 31, 2022 | Jan 2, 2022 | Jan 2, 2021 | Dec 28, 2019 | Dec 29, 2018 | Dec 30, 2017 | Jan 1, 2017 | Jan 3, 2016 | Dec 28, 2014 | Dec 29, 2013 | Dec 30, 2012 | Jan 1, 2012 | Jan 2, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia-Pacific, Africa Revenue | 13.59B | 13.76B | 23.45B | 17.27B | 18.98B | 18.47B | 18.75B | 17.13B | 12.57B | 12.35B | 13.44B | 13.38B | 16.95B | 17.13B | 11.08B |
| Asia-Pacific, Africa Revenue Growth | -1.18% | -41.34% | +35.74% | -8.98% | +2.78% | -1.53% | +9.50% | +36.19% | +1.85% | -8.15% | +0.45% | -21.03% | -1.07% | +54.64% | n/a |
| Europe Revenue | 20.21B | 20.41B | 16.79B | 23.59B | 15.14B | 15.55B | 14.83B | 13.42B | 15.77B | 15.99B | 18.95B | 18.6B | 29.83B | 28.91B | 15.51B |
| Europe Revenue Growth | -0.97% | +21.57% | -28.84% | +55.88% | -2.69% | +4.88% | +10.51% | -14.90% | -1.41% | -15.58% | +1.87% | -37.65% | +3.19% | +86.38% | n/a |
| United States Revenue | 50.3B | 46.44B | 48.58B | 47.16B | 43.13B | 42.1B | 41.88B | 39.86B | 37.81B | 35.69B | 34.78B | 31.91B | n/a | n/a | 29.45B |
| United States Revenue Growth | +8.31% | -4.40% | +3.02% | +9.33% | +2.46% | +0.51% | +5.07% | +5.43% | +5.95% | +2.60% | +9.00% | n/a | n/a | n/a | n/a |
| Western Hemisphere, Excluding U.S. Revenue | 4.71B | 4.55B | 6.13B | 5.75B | 5.33B | 5.94B | 6.11B | 6.04B | 5.73B | 6.04B | 7.16B | 7.42B | n/a | n/a | n/a |
| Western Hemisphere, Excluding U.S. Revenue Growth | +3.63% | -25.73% | +6.52% | +7.78% | -10.20% | -2.81% | +1.19% | +5.35% | -5.14% | -15.57% | -3.52% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 29, 2025 | Mar 30, 2025 | Dec 29, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Jul 2, 2023 | Apr 2, 2023 | Jan 1, 2023 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Jan 2, 2022 | Oct 3, 2021 | Jul 4, 2021 | Apr 4, 2021 | Jan 3, 2021 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 29, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 30, 2018 | Sep 30, 2018 | Jul 1, 2018 | Apr 1, 2018 | Dec 31, 2017 | Oct 1, 2017 | Jul 2, 2017 | Apr 2, 2017 | Jan 1, 2017 | Oct 2, 2016 | Jul 3, 2016 | Apr 3, 2016 | Jan 3, 2016 | Sep 27, 2015 | Jun 28, 2015 | Mar 29, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 5.89B | 5.01B | 6.25B | 5.28B | 5.48B | 5.06B | 5.51B | 5.1B | 5B | 4.51B | 7.41B | 4.67B | 5.93B | 5.64B | 7.65B | 5.8B | 5.97B | 5.23B | 6.46B | 5.33B | 4.89B | 5.2B | 6.04B | 5.37B | 5.55B | 5.22B | 5.99B | 5.54B | 5.74B | 5.26B | 6.03B | 5.42B | 5.29B | 4.76B | 5.31B | 4.77B | 5.18B | 4.69B | 5.89B | 5.08B | 5.38B | 4.85B |
| Selling, General, and Administrative Revenue Growth | +17.50% | -19.85% | +18.47% | -3.70% | +8.38% | -8.22% | +8.04% | +2.08% | +10.87% | -39.21% | +58.55% | -21.11% | +5.11% | -26.34% | +31.97% | -2.90% | +14.16% | -18.97% | +21.12% | +8.95% | -5.96% | -13.84% | +12.37% | -3.10% | +6.27% | -12.89% | +8.08% | -3.48% | +9.12% | -12.65% | +11.10% | +2.53% | +11.04% | -10.28% | +11.25% | -7.81% | +10.41% | -20.42% | +15.94% | -5.63% | +11.08% | n/a |
| Research and Development Revenue | 3.52B | 3.23B | 5.3B | 4.95B | 3.44B | 3.54B | 4.48B | 3.45B | 3.7B | 3.46B | 4.62B | 3.48B | 3.7B | 4.07B | 4.72B | 3.42B | 3.39B | 3.18B | 4.03B | 2.84B | 2.71B | 2.58B | 3.23B | 2.6B | 2.67B | 2.86B | 3.22B | 2.51B | 2.64B | 2.4B | 3.63B | 2.58B | 2.3B | 2.07B | 2.64B | 2.18B | 2.26B | 2.01B | 2.86B | 2.15B | 2.13B | 1.9B |
| Research and Development Revenue Growth | +9.02% | -39.13% | +6.99% | +43.95% | -2.88% | -20.94% | +29.97% | -6.91% | +7.18% | -25.28% | +32.68% | -5.89% | -9.06% | -13.73% | +37.93% | +0.82% | +6.80% | -21.18% | +41.97% | +4.91% | +4.92% | -20.17% | +24.36% | -2.51% | -6.72% | -11.35% | +28.55% | -4.96% | +9.78% | -33.87% | +40.62% | +12.59% | +10.92% | -21.59% | +21.21% | -3.80% | +12.47% | -29.71% | +32.96% | +1.17% | +12.11% | n/a |